Can mesenchymal stem cells survive under normal impaction force in revision total hip replacements?

被引:18
作者
Korda, M
Blunn, G
Phipps, K
Rust, P
Di Silvio, L
Coathup, M
Goodship, A
Hua, J [1 ]
机构
[1] UCL, Ctr Biomed Engn, Stanmore HA7 4LP, Middx, England
[2] UCL, Inst Orthopaed & Musculoskeletal Sci, Stanmore HA7 4LP, Middx, England
[3] Kings Coll London, Guys Kings & St Thomas Med & Dent Inst, London WC2R 2LS, England
来源
TISSUE ENGINEERING | 2006年 / 12卷 / 03期
关键词
D O I
10.1089/ten.2006.12.625
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Impaction allograft as a scaffold for bone-forming cells is a tissue-engineering approach for filling bone defects that are commonly encountered during revision total joint replacement (THR). The purpose of this in vitro study is to assess the viability of mesenchymal stem cells (MSC) grown on allograft following impaction using forces similar to those measured during revision total hip replacements. Impaction forces of 0, 3, 6, and 9 kN were used representing normal and high impact. The results showed that the viability in the 3 and 6 kN groups was not significantly reduced compared with that of the 0 kN group, while the survival of the MSCs was significantly reduced after 9 kN impaction force. This study suggests that the addition of MSCs to the allograft scaffold will survive normal impaction force in revision THR.
引用
收藏
页码:625 / 630
页数:6
相关论文
共 26 条
[1]  
[Anonymous], 2004, 1 ANN REP
[2]  
BOURN J, 2003, 956 HC NAT AUD OFF
[3]  
Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
[4]   Impacted cancellous graft plus cement in hip revision [J].
Cabanela, ME ;
Trousdale, RT ;
Berry, DJ .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2003, (417) :175-182
[5]  
ELTING JJ, 1995, CLIN ORTHOP RELAT R, P159
[6]   IMPACTED CANCELLOUS ALLOGRAFTS AND CEMENT FOR REVISION TOTAL HIP-ARTHROPLASTY [J].
GIE, GA ;
LINDER, L ;
LING, RSM ;
SIMON, IP ;
SLOOFF, TJJH ;
TIMPERLEY, AJ .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1993, 75 (01) :14-21
[7]  
GIE GA, 1993, ORTHOP CLIN N AM, V24, P717
[8]   Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis [J].
Harris, CT ;
Cooper, LF .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 68A (04) :747-755
[9]   Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect [J].
Kadiyala, S ;
Jaiswal, N ;
Bruder, SP .
TISSUE ENGINEERING, 1997, 3 (02) :173-185
[10]  
Kon E, 2000, J BIOMED MATER RES, V49, P328